학술논문
'학술논문'
에서 검색결과 212건 | 목록
1~10
Academic Journal
Recine F; Bongiovanni A; Riva N; Fausti V; De Vita A; Mercatali L; Liverani C; Miserocchi G; Amadori D; Ibrahim T
OncoTargets and Therapy, Vol Volume 10, Pp 1155-1164 (2017)
Academic Journal
OncoTargets and Therapy, Vol Volume 10, Pp 551-557 (2017)
Academic Journal
De Vita A; Mercatali L; Recine F; Pieri F; Riva N; Bongiovanni A; Liverani C; Spadazzi C; Miserocchi G; Amadori D; Ibrahim T
OncoTargets and Therapy, Vol Volume 9, Pp 6233-6246 (2016)
Academic Journal
Bongiovanni A; Riva N; Ricci M; Liverani C; La Manna F; De Vita A; Foca F; Mercatali L; Severi S; Amadori D; Ibrahim T
OncoTargets and Therapy, Vol 2015, Iss Issue 1, Pp 3613-3619 (2015)
Academic Journal
Bongiovanni A; Riva N; Calpona S; Ricci M; Gunelli E; Liverani C; La Manna F; De Vita A; Monti M; Severi S; Pieri F; Amadori E; Galassi R; Cavaliere D; Zaccaroni A; Tartaglia A; Lunedei V; Gardini A; Mercatali L; Amadori D; Ibrahim T
OncoTargets and Therapy, Vol 2014, Iss default, Pp 1919-1926 (2014)
Academic Journal
Calabrese C; Preclinic and Osteoncology Unit, Biosciences Laboratory, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) 'Dino Amadori', Meldola, Italy.; Miserocchi G; Preclinic and Osteoncology Unit, Biosciences Laboratory, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) 'Dino Amadori', Meldola, Italy.; De Vita A; Preclinic and Osteoncology Unit, Biosciences Laboratory, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) 'Dino Amadori', Meldola, Italy.; Spadazzi C; Preclinic and Osteoncology Unit, Biosciences Laboratory, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) 'Dino Amadori', Meldola, Italy.; Cocchi C; Preclinic and Osteoncology Unit, Biosciences Laboratory, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) 'Dino Amadori', Meldola, Italy.; Vanni S; Preclinic and Osteoncology Unit, Biosciences Laboratory, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) 'Dino Amadori', Meldola, Italy.; Gabellone S; Preclinic and Osteoncology Unit, Biosciences Laboratory, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) 'Dino Amadori', Meldola, Italy.; Martinelli G; Scientific Directorate, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) 'Dino Amadori', Meldola, Italy.; Ranallo N; Clinical and Experimental Oncology, Immunotherapy, Rare Cancers and Biological Resource Center, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) 'Dino Amadori', Meldola, Italy.; Bongiovanni A; Clinical and Experimental Oncology, Immunotherapy, Rare Cancers and Biological Resource Center, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) 'Dino Amadori', Meldola, Italy.; Liverani C; Preclinic and Osteoncology Unit, Biosciences Laboratory, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) 'Dino Amadori', Meldola, Italy.
Publisher: Blackwell Publishing Country of Publication: England NLM ID: 100897395 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1467-789X (Electronic) Linking ISSN: 14677881 NLM ISO Abbreviation: Obes Rev Subsets: MEDLINE
Academic Journal
Severi S; Nuclear Medicine and Radiometabolic Units, IRCCS Istituto Romagnolo per lo Studio dei Tumori 'Dino Amadori', Meldola, Italy.; Grassi I; Nuclear Medicine and Radiometabolic Units, IRCCS Istituto Romagnolo per lo Studio dei Tumori 'Dino Amadori', Meldola, Italy.; Bongiovanni A; Osteoncology and Rare Tumor Center, IRCCS Istituto Romagnolo per lo Studio dei Tumori 'Dino Amadori', Meldola, Italy; dr.bongiovanni@gmail.com.; Nicolini S; Nuclear Medicine and Radiometabolic Units, IRCCS Istituto Romagnolo per lo Studio dei Tumori 'Dino Amadori', Meldola, Italy.; Marini I; Nuclear Medicine and Radiometabolic Units, IRCCS Istituto Romagnolo per lo Studio dei Tumori 'Dino Amadori', Meldola, Italy.; Arpa D; Radiotherapy Unit, IRCCS Istituto Romagnolo per lo Studio dei Tumori 'Dino Amadori', Meldola, Emilia Romagna, Italy.; Ranallo N; Osteoncology and Rare Tumor Center, IRCCS Istituto Romagnolo per lo Studio dei Tumori 'Dino Amadori', Meldola, Italy.; Azzali I; Biostatistics and Clinical Trials, IRCCS Istituto Romagnolo per lo Studio dei Tumori 'Dino Amadori', Meldola, Italy.; Di Iorio V; Oncological Pharmacy Unit, IRCCS Istituto Romagnolo per lo Studio dei Tumori 'Dino Amadori', Meldola, Emilia Romagna, Italy.; Sarnelli A; Medical Physics Unit, IRCCS Istituto Romagnolo per lo Studio dei Tumori 'Dino Amadori', Meldola, Italy.; Manuela M; Biostatistics and Clinical Trials, IRCCS Istituto Romagnolo per lo Studio dei Tumori 'Dino Amadori', Meldola, Italy.; Amadori E; Radiology Unit, IRCCS Istituto Romagnolo per lo Studio dei Tumori 'Dino Amadori', Meldola, Italy.; Fabbri L; Radiotherapy Unit, IRCCS Istituto Romagnolo per lo Studio dei Tumori 'Dino Amadori', Meldola, Emilia Romagna, Italy.; Bartolini D; Pathology Unit, 'Maurizio Bufalini' Hospital, Cesena, Italy.; Tosatto L; Department of Neurosciences, Neurosurgery Division 'M Bufalini' Hospital, Cesena, Emilia Romagna, Italy.; Di Meco F; Department of Neurosurgery, Fondazione IRCCS Istituto Neurologico C. Besta, Milan, Italy.; Department of Neurosurgery, Johns Hopkins University, Baltimore, Maryland.; Gurrieri L; Osteoncology and Rare Tumor Center, IRCCS Istituto Romagnolo per lo Studio dei Tumori 'Dino Amadori', Meldola, Italy.; Riva N; Osteoncology and Rare Tumor Center, IRCCS Istituto Romagnolo per lo Studio dei Tumori 'Dino Amadori', Meldola, Italy.; Calabro L; Department of Oncology, University Hospital of Ferrara, Cona, Italy; and.; Department of Translational Medicine, University of Ferrara, Ferrara, Italy.; Matteucci F; Nuclear Medicine and Radiometabolic Units, IRCCS Istituto Romagnolo per lo Studio dei Tumori 'Dino Amadori', Meldola, Italy.; Paganelli G; Nuclear Medicine and Radiometabolic Units, IRCCS Istituto Romagnolo per lo Studio dei Tumori 'Dino Amadori', Meldola, Italy.; Sansovini M; Nuclear Medicine and Radiometabolic Units, IRCCS Istituto Romagnolo per lo Studio dei Tumori 'Dino Amadori', Meldola, Italy.
Publisher: Society of Nuclear Medicine Country of Publication: United States NLM ID: 0217410 Publication Model: Electronic Cited Medium: Internet ISSN: 1535-5667 (Electronic) Linking ISSN: 01615505 NLM ISO Abbreviation: J Nucl Med Subsets: MEDLINE
Academic Journal
Laganà M; Medical Oncology Unit, Department of Medical and Surgical Specialties, Radiological Sciences, and Public Health, University of Brescia, ASST Spedali Civili, Brescia, Italy.; Habra MA; Department of Endocrine Neoplasia and Hormonal Disorders, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Remde H; Department of Internal Medicine I, Division of Endocrinology and Diabetes, University Hospital Wuerzburg, Wuerzburg, Germany.; Almeida MQ; Unidade de Adrenal, Laboratório de Endocrinologia Molecular e Celular LIM25, Divisão de Endocrinologia, Hospital das Clínicas & Instituto do Câncer do Estado de São Paulo (ICESP), Faculdade de Medicina, Universidade de São Paulo, Sao Paulo, Brazil.; Cosentini D; Medical Oncology Unit, Department of Medical and Surgical Specialties, Radiological Sciences, and Public Health, University of Brescia, ASST Spedali Civili, Brescia, Italy. Electronic address: d.cosentini@unibs.it.; Pusceddu S; Department of Medical Oncology, Fondazione IRCCS INT Istituto Nazionale Tumori Milano, Milan, Italy.; Grana CM; Division of Nuclear Medicine, IRCCS IEO European Institute of Oncology, Milano, Italy.; Corssmit EPM; Division of Endocrinology, Department of Internal Medicine, Leiden University Medical Center, Leiden, the Netherlands.; Bongiovanni A; Osteoncology and Rare Tumors Center (CDO-TR), IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST 'Dino Amadori'), Meldola, Italy.; De Filpo G; Department of Experimental and Clinical Biomedical Sciences, University of Florence, Florence, Italy.; Lim ES; Department of Endocrinology, St. Bartholomew's Hospital, Barts Health NHS Trust, London, UK.; Zamparini M; Medical Oncology Unit, Department of Medical and Surgical Specialties, Radiological Sciences, and Public Health, University of Brescia, ASST Spedali Civili, Brescia, Italy.; Grisanti S; Medical Oncology Unit, Department of Medical and Surgical Specialties, Radiological Sciences, and Public Health, University of Brescia, ASST Spedali Civili, Brescia, Italy.; Deutschbein T; Department of Internal Medicine I, Division of Endocrinology and Diabetes, University Hospital Wuerzburg, Wuerzburg, Germany; Medicover Oldenburg MVZ, Oldenburg, Germany.; Fassnacht M; Department of Internal Medicine I, Division of Endocrinology and Diabetes, University Hospital Wuerzburg, Wuerzburg, Germany.; Fagundes GFC; Unidade de Adrenal, Laboratório de Endocrinologia Molecular e Celular LIM25, Divisão de Endocrinologia, Hospital das Clínicas & Instituto do Câncer do Estado de São Paulo (ICESP), Faculdade de Medicina, Universidade de São Paulo, Sao Paulo, Brazil.; Pereira MAA; Unidade de Adrenal, Laboratório de Endocrinologia Molecular e Celular LIM25, Divisão de Endocrinologia, Hospital das Clínicas & Instituto do Câncer do Estado de São Paulo (ICESP), Faculdade de Medicina, Universidade de São Paulo, Sao Paulo, Brazil.; Oldani S; Department of Medical Oncology, Fondazione IRCCS INT Istituto Nazionale Tumori Milano, Milan, Italy.; Rota S; Department of Medical Oncology, Fondazione IRCCS INT Istituto Nazionale Tumori Milano, Milan, Italy.; Prinzi N; Department of Medical Oncology, Fondazione IRCCS INT Istituto Nazionale Tumori Milano, Milan, Italy.; Jimenez C; Department of Endocrine Neoplasia and Hormonal Disorders, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Berruti A; Medical Oncology Unit, Department of Medical and Surgical Specialties, Radiological Sciences, and Public Health, University of Brescia, ASST Spedali Civili, Brescia, Italy.
Publisher: Elsevier Science Ltd Country of Publication: England NLM ID: 9005373 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0852 (Electronic) Linking ISSN: 09598049 NLM ISO Abbreviation: Eur J Cancer Subsets: MEDLINE
Academic Journal
Bongiovanni A; Osteoncology and Rare Tumor Center (CDO-TR), IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) 'Dino Amadori', Meldola, Italy.; Liverani C; Bioscience Laboratory, Preclinic and Osteoncology Unit, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) 'Dino Amadori', Meldola, Italy. Electronic address: chiara.liverani@irst.emr.it.; Foca F; Unit of Biostatistics and Clinical Trials, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) 'Dino Amadori', Meldola, Italy.; Bergamo F; Medical Oncology Unit 1, IOV-Veneto Institute of Oncology IRCCS, Padua, Italy.; Leo S; Department of Medical Oncology, 'Vito Fazzi' Hospital, Lecce, Italy.; Pusceddu S; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, ENETS Center of Excellence, Milan, Italy.; Gelsomino F; Department of Oncology and Hematology, Division of Oncology, University Hospital of Modena, Modena, Italy.; Brizzi MP; Department of Oncology, 'San Luigi Gonzaga' University Hospital, University of Turin, Orbassano, Italy.; Di Meglio G; Medical Oncology Unit, Bolzano Hospital, Bolzano, Italy.; Spada F; Division of Gastrointestinal Medical Oncology and Neuroendocrine Tumors, European Institute of Oncology (IEO) IRCCS, Milan, Italy.; Tamberi S; Medical Oncology Unit, 'Degli Infermi' Hospital, Faenza, Italy.; Lolli I; Medical Oncology Unit, National Institute of Gastroenterology, IRCCS 'Saverio De Bellis', Castellana Grotte, Italy.; Cives M; Department of Interdisciplinary Medicine, 'Aldo Moro' University of Bari, Bari, Italy; Division of Medical Oncology, Azienda Ospedaliero Universitaria Consorziale Policlinico di Bari, Bari, Italy.; Marconcini R; Medical Oncology Unit, Azienda Ospedaliero Universitaria Pisana, Pisa, Italy.; Pucci F; Medical Oncology Unit, University Hospital of Parma, Parma, Italy.; Berardi R; Department of Medical Oncology, Università Politecnica delle Marche, Azienda Ospedaliero Universitaria Ospedali Riuniti di Ancona, Ancona, Italy.; Antonuzzo L; Clinical Oncology Unit, Careggi University Hospital, Florence, Italy; Department of Experimental and Clinical Medicine, University of Florence, Italy.; Badalamenti G; Department of Surgical, Oncological and Oral Sciences, Section of Medical Oncology, University of Palermo, Palermo, Italy.; Santini D; Department of Medical Oncology, University Campus Bio-Medico, Rome, Italy.; Recine F; Medical Oncology Unit, Azienda Ospedaliera 'San Giovanni Addolorata', Rome, Italy.; Vanni S; Bioscience Laboratory, Preclinic and Osteoncology Unit, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) 'Dino Amadori', Meldola, Italy.; Tebaldi M; Unit of Biostatistics and Clinical Trials, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) 'Dino Amadori', Meldola, Italy.; Severi S; Nuclear Medicine and Radiometabolic Units, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) 'Dino Amadori', Meldola, Italy.; Rudnas B; Unit of Biostatistics and Clinical Trials, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) 'Dino Amadori', Meldola, Italy.; Nanni O; Unit of Biostatistics and Clinical Trials, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) 'Dino Amadori', Meldola, Italy.; Ranallo N; Osteoncology and Rare Tumor Center (CDO-TR), IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) 'Dino Amadori', Meldola, Italy.; Crudi L; Department of Oncology, University Hospital of Ferrara, Cona, Italy.; Calabrò L; Oncology Pharmacy Unit, IRCCS Istituto Romagnolo per lo Studio dei Tumori 'Dino Amadori', 47014 Meldola, Italy; Department of Translational Medicine, University of Ferrara, Ferrara, Italy.; Ibrahim T; Osteoncology and Rare Tumor Center (CDO-TR), IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) 'Dino Amadori', Meldola, Italy; Osteoncology, Bone and Soft Tissue Sarcomas and Innovative Therapies Unit, IRCCS Istituto Ortopedico Rizzoli, Bologna, Italy.
Publisher: Elsevier Science Ltd Country of Publication: England NLM ID: 9005373 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0852 (Electronic) Linking ISSN: 09598049 NLM ISO Abbreviation: Eur J Cancer Subsets: MEDLINE
Academic Journal
Lefèvre G; University of Lille, Institut National de la Santé et de la Recherche Médicale (INSERM), Centre Hospitalier Universitaire (CHU) Lille, and Institute for Translational Research in Inflammation (INFINITE), Lille, France; Institut d'Immunologie, CHU Lille, Lille, France; National Reference Center for Hypereosinophilic Syndromes (CEREO). Electronic address: guillaume.lefevre@chu-lille.fr.; Gibier JB; University of Lille, Institut de Pathologie, Centre de Biopathologie, CHU Lille, Lille, France.; Bongiovanni A; Centre National de la Recherche Scientifique (CNRS), INSERM, CHU Lille, University of Lille, Institut Pasteur de Lille, Lille, France.; Lhermitte L; Laboratoire d'Onco-Hématologie, Hôpital Necker-Enfants Malades, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France; University of Paris, Institut Imagine, INSERM, Paris, France; French Reference Center for Mastocytosis (CEREMAST), Hôpital Necker-Enfants Malades, AP-HP, Paris, France.; Rossignol J; University of Paris, Institut Imagine, INSERM, Paris, France; French Reference Center for Mastocytosis (CEREMAST), Hôpital Necker-Enfants Malades, AP-HP, Paris, France; Department of Hematology, Hôpital Necker-Enfants Malades, AP-HP, Paris, France.; Anglo E; University of Lille, Institut National de la Santé et de la Recherche Médicale (INSERM), Centre Hospitalier Universitaire (CHU) Lille, and Institute for Translational Research in Inflammation (INFINITE), Lille, France; Institut d'Immunologie, CHU Lille, Lille, France.; Dendooven A; University of Lille, Institut National de la Santé et de la Recherche Médicale (INSERM), Centre Hospitalier Universitaire (CHU) Lille, and Institute for Translational Research in Inflammation (INFINITE), Lille, France; Institut d'Immunologie, CHU Lille, Lille, France.; Dubois R; University of Lille, Institut de Pathologie, Centre de Biopathologie, CHU Lille, Lille, France.; Terriou L; University of Lille, Institut National de la Santé et de la Recherche Médicale (INSERM), Centre Hospitalier Universitaire (CHU) Lille, and Institute for Translational Research in Inflammation (INFINITE), Lille, France; National Reference Center for Hypereosinophilic Syndromes (CEREO); Département de Médecine Interne et Immunologie Clinique, CHU Lille, Lille, France.; Launay D; University of Lille, Institut National de la Santé et de la Recherche Médicale (INSERM), Centre Hospitalier Universitaire (CHU) Lille, and Institute for Translational Research in Inflammation (INFINITE), Lille, France; National Reference Center for Hypereosinophilic Syndromes (CEREO); Département de Médecine Interne et Immunologie Clinique, CHU Lille, Lille, France.; Barete S; CEREMAST, AP-HP, Groupe Hospitalier Pitié-Salpêtrière, Unit de Dermatologie, Sorbonne Université Paris, Paris, France.; Esnault S; University of Lille, Institut National de la Santé et de la Recherche Médicale (INSERM), Centre Hospitalier Universitaire (CHU) Lille, and Institute for Translational Research in Inflammation (INFINITE), Lille, France; Institut d'Immunologie, CHU Lille, Lille, France; Department of Medicine, Division of Allergy, Pulmonary, and Critical Care Medicine, University of Wisconsin-Madison School of Medicine and Public Health, Madison, Wis.; Frenzel L; University of Paris, Institut Imagine, INSERM, Paris, France; French Reference Center for Mastocytosis (CEREMAST), Hôpital Necker-Enfants Malades, AP-HP, Paris, France; Department of Hematology, Hôpital Necker-Enfants Malades, AP-HP, Paris, France.; Gourguechon C; Department of Hematology, CHU Amiens, Amiens, France.; Ballul T; University of Paris, Institut Imagine, INSERM, Paris, France; French Reference Center for Mastocytosis (CEREMAST), Hôpital Necker-Enfants Malades, AP-HP, Paris, France; Department of Hematology, Hôpital Necker-Enfants Malades, AP-HP, Paris, France.; Dezoteux F; University of Lille, Institut National de la Santé et de la Recherche Médicale (INSERM), Centre Hospitalier Universitaire (CHU) Lille, and Institute for Translational Research in Inflammation (INFINITE), Lille, France; National Reference Center for Hypereosinophilic Syndromes (CEREO); Department of Dermatology, CHU Lille, Lille, France.; Staumont-Salle D; University of Lille, Institut National de la Santé et de la Recherche Médicale (INSERM), Centre Hospitalier Universitaire (CHU) Lille, and Institute for Translational Research in Inflammation (INFINITE), Lille, France; National Reference Center for Hypereosinophilic Syndromes (CEREO); Department of Dermatology, CHU Lille, Lille, France.; Copin MC; Department of Pathology, CHU Angers, University of Angers, INSERM, CNRS, CRCI(2)NA, Angers, France.; Rignault-Bricard R; University of Paris, Institut Imagine, INSERM, Paris, France.; Maciel TT; University of Paris, Institut Imagine, INSERM, Paris, France.; Damaj G; Institut d'Hématologie, University of Caen Normandie, Caen, France.; Tardivel M; Centre National de la Recherche Scientifique (CNRS), INSERM, CHU Lille, University of Lille, Institut Pasteur de Lille, Lille, France.; Crinquette-Verhasselt M; University of Lille, Institut de Pathologie, Centre de Biopathologie, CHU Lille, Lille, France.; Dubreuil P; Signaling, Hematopoiesis, and Mechanism of Oncogenesis (CRCM), CEREMAST, and Association Française pour les Initiatives de Recherche sur le Mastocyte et les Mastocytose (AFIRMM) studies, INSERM U1068; Institut Paoli-Calmettes; UM105, Aix-Marseille University; and CNRS, UMR7258, Marseille, France.; Maouche-Chrétien L; University of Paris, Institut Imagine, INSERM, Paris, France.; Bruneau J; University of Paris, Institut Imagine, INSERM, Paris, France; French Reference Center for Mastocytosis (CEREMAST), Hôpital Necker-Enfants Malades, AP-HP, Paris, France; Department of Pathology, Hôpital Necker-Enfants Malades, AP-HP, Paris, France.; Lortholary O; University of Paris, Institut Imagine, INSERM, Paris, France; French Reference Center for Mastocytosis (CEREMAST), Hôpital Necker-Enfants Malades, AP-HP, Paris, France.; Duployez N; CNRS, INSERM, CHU Lille, Cancer Heterogeneity, Plasticity, and Resistance to Therapies (CANTHER), University of Lille, Institut d'Hématologie, CHU Lille, Lille, France.; Behal H; University of Lille, CHU Lille, Evaluation des Technologies de Santé et des Pratiques Médicales (METRICS), Lille, France.; Molina TJ; University of Paris, Institut Imagine, INSERM, Paris, France; Signaling, Hematopoiesis, and Mechanism of Oncogenesis (CRCM), CEREMAST, and Association Française pour les Initiatives de Recherche sur le Mastocyte et les Mastocytose (AFIRMM) studies, INSERM U1068; Institut Paoli-Calmettes; UM105, Aix-Marseille University; and CNRS, UMR7258, Marseille, France.; Hermine O; University of Paris, Institut Imagine, INSERM, Paris, France; French Reference Center for Mastocytosis (CEREMAST), Hôpital Necker-Enfants Malades, AP-HP, Paris, France; Department of Hematology, Hôpital Necker-Enfants Malades, AP-HP, Paris, France. Electronic address: olivier.hermine@aphp.fr.
Publisher: Mosby Country of Publication: United States NLM ID: 1275002 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-6825 (Electronic) Linking ISSN: 00916749 NLM ISO Abbreviation: J Allergy Clin Immunol Subsets: MEDLINE
검색 결과 제한하기
제한된 항목
[AR] Bongiovanni A
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어